TigonTalker
@TigonTalker
Followers
503
Following
22K
Media
14
Statuses
4K
Data, poker, comedy, truth, life hacks, investing and helping others. $THETA $XRP $HBAR $GME $NWBO
Joined November 2021
$NWBO It's interesting that Dr. Timothy Cloughesy's work was cited in the FDA new guidance on Bayesian Methodology. Dr. Timothy Cloughesy is also the PI of the combo trial. Does it seem like that FDA is trying to get the regulatory framework set up for the revolutionary
0
2
9
Theta's foundational template allows organizations to grow and add new AI services while capturing revenue. No blockchain or integration work needed for the customer. #Theta #AI #EdgeCloud
1
6
16
The pivot from BTC mining infrastructure to AI compute infrastructure continues... $THETA #EdgeCloud $TFUEL
BITDEER LIQUIDATES ENTIRE BITCOIN TREASURY The miner has sold 100% of its corporate BTC holdings. • 943.1 BTC from reserves sold • 189.8 BTC newly mined sold • Balance now: 0 BTC Proceeds are being redirected toward data center expansion and AI cloud infrastructure.
3
7
40
$NWBO Merck has been bragging about 20 new growth drivers, almost all of which has blockbuster potential for the whole year of 2025. Not sure if it helps its sp which may be supported partly by dividend increase. Merck still maintain its optimism on 20 new growth drivers with
fiercepharma.com
Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its post-Keytruda future with what it foresees as a host of major sales opportu |...
Just enough to start buyout discussions with #NWBO!!!! "Since September 2025... 5 months to date... Merck's Market Cap has increased by... are you ready for this... $110 BILLION DOLLARS" https://t.co/erlbJ0mQKf
1
5
26
There is a poster on X claiming that $GME short interest is ~700% of shares outstanding. I believe he does some clever reverse engineering to discover how markets are made. He claims buy volume and short sell volume track together as part of the evidence to start his theory off.
227
301
3K
$NWBO Professor Keyoumars Ashkan said the following for DCVax-L But there's much more to come so future horizon opportunities are immense https://t.co/pOnVF8wULg
@andrewcaravello has been elaborating a lot about how DCVax platform developed by $NWBO can easily incorporate
0
6
55
Who hear remembers when enemies of $NWBO complained to my board and to my investors about me supporting this amazing #immunotherapy company??? I think I need to do some more tweets on the powerful dendritic cell and the amazing future of $NWBO
4
10
109
🚨 Matthew McConaughey just told Hollywood actors they're cooked. "AI is here and it's going to take their jobs." His advice? "Copyright your likeness and voice. There's too much money to be made in AI to stop it." Why pay McConaughey $20 million when you can AI-generate him
801
3K
22K
Update: Last week, the Defendants’ Motion was DENIED. This is a big win for $NWBO. $NWBO Thanks Hoff.
$NWBO Spoofing Case Update – Motion Battle The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) The Docket: https://t.co/D0tfjlyLOe In this post we will discuss the Court’s ruling on a recent discovery related motion filed by Defendants.
1
8
61
Go #NWBO!!! $NWBO's 1/26/2026 response to the US Patent Office materially strengthens its chance of securing the U.S. Combination (DCVAX + PD1/PDL1) patent. Here is AI's take. Any day now? Go $NWBO!!!! https://t.co/JUlPt5jhzy
1
4
54
🩸How $NWBO Integrated Platelet Biology, Dendritic Cell Licensing, and a Silent Immune Engine ⏱️ Estimated Reading Time: 10–12 minutes 🧪 TL;DR: The Engine Behind the Silence Mill Creek’s PLTMax produces pooled tumor lysate rich in vascular antigens. Mayo proved the lysate
2
12
68
NTT Digital, the Web3 arm of NTT Group (a $100B company with 340K employees), joins the enterprise validator node set. This unlocks new possibilities in telecommunication, AI, and cloud services. #Web3 #NTTDigital
2
11
59
WOW! FDA’s Jan 2026 Bayesian draft explicitly puts GBM (by name!) in a setting where randomization is limited and formally recognizes external control data as part of the acceptable framework. FDA’s subtext to #NWBO: Here’s your BLA playbook. Use it. CEO ramps up US $NWBO mfg.!
🧬The 2026 Regulatory Paradigm Shift $NWBO #DCVax-L now sits inside a regulatory environment that has shifted in posture, not in statute. The legal authority is not new. Since 1997, FDA has had the ability to approve a therapy on the basis of one adequate and well-controlled
0
3
27
@andrewcaravello 1. Soluble TNF inhibition (XPro1595): Neutralizes sTNF, reducing TNFR1-driven inflammation, lowering microglial activation and neurotoxic cytokines (e.g., IL-1β, IL-6) without blocking tmTNF-mediated defense. 2. Tolerogenic DCVax instruction: Antigen-loaded tolDCs (e.g., Aβ/tau)
0
3
17
@grok Can you map the full mechanism step-by-step — from soluble TNF inhibition to tolerogenic #DCVax instruction to regulatory CD4 programming to CNS-border effects and microglial state stabilization in #Alzheimer’s?
1
4
9